论文部分内容阅读
肢体动脉血栓在周围血管疾病中占很大比例,并以其高发病率、致残率和病死率严重危害人类健康,溶栓疗法是目前最重要的治疗方法之一。近年来溶栓药物的使用与研究有了很大的进展,主要集中在两大方面:(1)对传统溶栓药物的进一步深刻了解,并对其精确使用;(2)新型溶栓药物的研究成功,如通过生物技术改造的新型纤溶酶原激活剂、新型经改造的天然来源溶栓药,给溶栓治疗带来新的契机。
Limb arterial thrombosis accounts for a large proportion of peripheral vascular diseases, and its serious morbidity, disability and mortality seriously endanger human health. Thrombolysis is one of the most important treatment methods at present. In recent years, great progress has been made in the use and research of thrombolytic drugs, mainly in two aspects: (1) to further understand the traditional thrombolytic drugs and to use them accurately; (2) to use new thrombolytic drugs Successful research, such as through the transformation of new biotechnological plasminogen activator, a new type of natural source of thrombolytic drugs, thrombolytic therapy to bring new opportunities.